Table 3_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Table 1_Global, regional, and national epilepsy of unknown cause incidence and mortality, 1990–2036: cross-national health inequalities and predictive analytics.xlsx by Lijun Wang (176511)

“…Projections for the next 15 years show that both ASIR (71.04%) and ASYR (55.74%) will increase in most countries or regions while ASDR (75.41%) will decrease in most countries or regions.</p>Conclusion<p>Health inequalities in the world’s idiopathic epileptic YLDs will continue to increase in the future, and the disease burden of idiopathic epileptic YLDs will become more concentrated in low-income countries.…”

Table 2_Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-ana... by Wenting Cai (1547938)

“…The efficacy indicators were change in the Mini Mental State Examination (MMSE), Clinical Dementia Rating Scale Sum of Boxes (CDR-SB), Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog), Alzheimer’s Disease Cooperative Study-Activities of Daily Living Scale (ADCS-ADL) from baseline until the time of efficacy observation. …”

Table 1_Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer’s disease: a systematic review and network meta-ana... by Wenting Cai (1547938)

“…The efficacy indicators were change in the Mini Mental State Examination (MMSE), Clinical Dementia Rating Scale Sum of Boxes (CDR-SB), Alzheimer’s Disease Assessment Scale-Cognitive (ADAS-Cog), Alzheimer’s Disease Cooperative Study-Activities of Daily Living Scale (ADCS-ADL) from baseline until the time of efficacy observation. …”

Table 1_Triglyceride-cholesterol-body weight index associated with the risk of metabolic dysfunction-associated steatotic liver disease: a population-based cross-sectional study.do... by Li Fan (170266)

“…Background<p>The triglyceride-cholesterol-body weight index (TCBI), a novel parameter integrating serum triglycerides (TG), total cholesterol (TC), and body weight (BW), has not been comprehensively investigated in relation to metabolic dysfunction-associated steatotic liver disease (MASLD). …”

Data Sheet 1_Global trends and inequities in smoking-attributable aortic aneurysm burden from 1990 to 2021 with future projections.docx by Shuai Zhang (115662)

“…This study leverages data from the Global Burden of Disease Study to analyze trends in smoking-related AA burden from 1990 to 2021, focusing on mortality, disability-adjusted life years (DALYs), and socioeconomic determinants.…”

Identified cleavage sites in proteins of the complement and coagulation cascade. by Nina Germitsch (19739413)

Albendazole-quercetin co-therapy suppresses brain inflammasome activation and apoptosis in mice with angiostrongyliasis. by Ho Yin Pekkle Lam (11015046)

Data Sheet 1_Antidiabetic and lipid-lowering therapy modify the association between triglyceride–glucose index and acute kidney injury in critically ill patients with coronary arte... by Yuehang Yang (17612601)

“…With the use of antidiabetic drugs, this association remained significant but was attenuated (OR 1.480, 95% CI 1.190–1.853), with a significant interaction observed between the use of antidiabetic drugs and the TyG index in relation to AKI risk (P for interaction = 0.040). …”

Global metabolite profiling of SARS-CoV-2 inoculated A549 cells. by Emma K. Loveday (18946397)

Global metabolite profiling of SARS-CoV-2 infected ACE2-A549 cells. by Emma K. Loveday (18946397)

Treatment with a PPARγ agonist improved impaired mitochondrial quality control, oxidative stress, and apoptosis induced by calcium oxalate crystals in the kidney. by Junfa Liu (209177)

Odds ratios and 95% confidence intervals (95% CI) for the association between perceived stress score (PSS) and high AL using Model 1, Model 2, Model 3, and Model 4 (sequentially, l... by Faith Morley (22022118)

Data Sheet 1_Tobacco- and alcohol-attributable burden of early-onset lip, oral cavity, and pharyngeal cancer in 204 countries and territories from 1990 to 2019, with projections to... by Xingzhu Dai (11086206)

“…Furthermore, projections have also indicated an expected increase in the age-standardized mortality for tobacco- and alcohol-attributable early-onset LOC and OPC.</p>Conclusions<p>Significant regional and demographic disparities in tobacco and alcohol-related early-onset LOC and OPC burden and their attributable proportion highlight a need for tailored age- and region-appropriate interventions to reduce the future LOC and OPC burden among young adults.…”

A549 cells have quantifiably different metabolic responses to SARS-CoV-2. by Emma K. Loveday (18946397)

Supplementary file 2_A multi-omics study of magnesium sulfate to improve prognosis in sepsis-related encephalopathy: integrating clinical data-driven network pharmacology.xlsx by Yingming Kong (7330424)

Supplementary file 1_A multi-omics study of magnesium sulfate to improve prognosis in sepsis-related encephalopathy: integrating clinical data-driven network pharmacology.docx by Yingming Kong (7330424)

Treatment with a PPARγ agonist improved COM-induced apoptosis in HK2 cells. by Junfa Liu (209177)

Treatment with COM induced mitochondrial fission in HK2 cells. by Junfa Liu (209177)

Treatment with a PPARγ agonist improved COM-induced mitochondrial fragmentation and ROS levels in HK2 cells. by Junfa Liu (209177)